Assignee
PRIMEVAX IMMUNO ONCOLOGY INC
US·10 granted patents·4 pending applications·33 citations·filing 2016–2022
Top patents by PatentIndex Score
14 records- 0191US10946080B2Compositions and methods for combination therapy with dengue virus and dendritic cellsPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2019·Granted Mar 16, 2021·3 cites·20 claims
- 0291US10675304B2Combination immunotherapies for treatment of cancerPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2019·Granted Jun 9, 2020·4 cites·14 claims
- 0391US9849167B2Compositions and methods for combination therapy with dengue virus and dendritic cellsPRIMEVAX IMMUNO-ONCOLOGY INC·Filed 2017·Granted Dec 26, 2017·8 cites·9 claims
- 0490US11357795B2Combination immunotherapies for treatment of cancerPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2020·Granted Jun 14, 2022·2 cites·9 claims
- 0590US9730989B2Compositions and methods for combination therapy with dengue virus and dendritic cellsPRIMEVAX IMMUNO-ONCOLOGY INC·Filed 2016·Granted Aug 15, 2017·7 cites·20 claims
- 0687US10357553B2Compositions and methods for combination therapy with dengue virus and dendritic cellsPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2018·Granted Jul 23, 2019·4 cites·23 claims
- 0787US10159727B2Compositions and methods for combination therapy with dengue virus and dendritic cellsPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2017·Granted Dec 25, 2018·4 cites·14 claims
- 0879US12377115B2Combination immunotherapies for treatment of cancerPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2022·Granted Aug 5, 2025·0 cites·9 claims
- 0978US10765727B2Compositions and methods for producing dendritic cellsPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2016·Granted Sep 8, 2020·1 cites·11 claims
- 1073US2021187086A1Compositions and methods for combination therapy with dengue virus and dendritic cellsPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 1169US12059443B2Method for treating cancer using dengue virus serotype 1 (DENV-1)PRIMEVAX IMMUNO ONCOLOGY INC·Filed 2020·Granted Aug 13, 2024·0 cites·12 claims
- 1259US2020078424A1Compositions and methods for therapy with dengue virusPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 1359US2020360497A1Compositions and methods for producing dendritic cellsPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1451US2020121745A1Compositions and methods for cancer therapy with dengue virus and dendritic cellsPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PRIMEVAX IMMUNO ONCOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →